Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene
- PMID: 3380801
- PMCID: PMC280450
- DOI: 10.1073/pnas.85.12.4463
Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene
Abstract
High metastatic clones of the murine 3LL carcinoma express greatly reduced levels of H-2Kb major histocompatibility complex class I antigens, while low metastatic clones of the same tumor express high levels of H-2Kb. Induced expression of this antigen after transfection with the H-2Kb gene resulted in conversion of a metastatic to a non- or low-metastatic phenotype. Unlike the parental cells, transfected cells are potent inducers of H-2Kb-restricted syngeneic cytotoxic lymphocytes that kill the Kb-positive clones and cross-react with parental nontransfected cells. Preimmunization of mice with Kb-positive transfectants conferred protection against metastatic spread of malignant cells. Moreover, immunotherapy of metastasis was achieved by immunization with the H-2Kb-transfected cells of animals already carrying a growing local tumor of the parental cells.
Similar articles
-
Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.Gene Ther. 1995 Dec;2(10):757-65. Gene Ther. 1995. PMID: 8750016
-
H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence.J Immunogenet. 1989 Aug-Oct;16(4-5):291-303. doi: 10.1111/j.1744-313x.1989.tb00475.x. J Immunogenet. 1989. PMID: 2639904
-
Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.Cancer Res. 1989 May 1;49(9):2366-73. Cancer Res. 1989. PMID: 2784997
-
MHC class I genes controlling the metastatic phenotype of tumor cells.Semin Cancer Biol. 1991 Oct;2(5):337-46. Semin Cancer Biol. 1991. PMID: 1773049 Review.
-
Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.Semin Cancer Biol. 1991 Oct;2(5):329-36. Semin Cancer Biol. 1991. PMID: 1773048 Review.
Cited by
-
Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.Clin Exp Metastasis. 1993 Nov;11(6):439-52. doi: 10.1007/BF00054935. Clin Exp Metastasis. 1993. PMID: 8222393
-
Breast cancer gene therapy: transgenic immunotherapy.Breast Cancer Res Treat. 1994;31(2-3):349-56. doi: 10.1007/BF00666167. Breast Cancer Res Treat. 1994. PMID: 7881111 Review.
-
Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.J Virol. 1997 Feb;71(2):965-70. doi: 10.1128/JVI.71.2.965-970.1997. J Virol. 1997. PMID: 8995614 Free PMC article.
-
Potential applications of gene therapy in the patient with cancer.Drugs Aging. 2000 Aug;17(2):121-32. doi: 10.2165/00002512-200017020-00004. Drugs Aging. 2000. PMID: 10984200 Review.
-
Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.PLoS One. 2008 Aug 29;3(8):e3097. doi: 10.1371/journal.pone.0003097. PLoS One. 2008. PMID: 18769733 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical